Child-onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13

European Journal of Haematology
An-Sofie SchelpeKristin Jochmans

Abstract

Patients suffering from congenital thrombotic thrombocytopenic purpura (cTTP) have a deficiency in ADAMTS13 due to mutations in their ADAMTS13 gene. The aim of this study was to determine ADAMTS13 parameters (activity, antigen, and mutations), to investigate if the propositus suffered from child-onset cTTP, and to study the in vitro effect of the ADAMTS13 mutations. ADAMTS13 activity and antigen were determined using the FRETS VWF73 assay and ELISA and ADAMTS13 mutations via sequencing of the exons. Mutant proteins were expressed in Chinese hamster ovary cells, and their expression was studied using fluorescence microscopy and ELISA. Molecular modeling was used to evaluate the effect of the mutations on ADAMTS13 structure and stability. The propositus was diagnosed with cTTP at the age of 20. ADAMTS13 activity was below 10%, and 2 compound heterozygous mutations, the p.R498C point and the p.G259PfsX133 frameshift mutation, were identified. Expression of ADAMTS13 mutants revealed that the p.R498C and the p.G259PfsX133 mutation cause secretion and translation defects in vitro, respectively. Molecular modeling showed that the R498 intra-domain interactions are lacking in the p.R498C mutant, resulting in protein instability. The AD...Continue Reading

References

Aug 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Koichi KokameYoshihiro Fujimura
Mar 4, 2003·Nature Reviews. Molecular Cell Biology·Lars Ellgaard, Ari Helenius
Jan 17, 2004·Seminars in Hematology·Koichi Kokame, Toshiyuki Miyata
Apr 2, 2005·British Journal of Haematology·Koichi KokameToshiyuki Miyata
Mar 15, 2006·The Journal of Experimental Medicine·Anil K ChauhanDenisa D Wagner
Sep 28, 2006·Thrombosis and Haemostasis·Roberta DonadelliUNKNOWN International Registry of Recurrent and Familial HUS/TTP
Jun 17, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Simon F De MeyerKaren Vanhoorelbeke
Nov 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Masashi AkiyamaToshiyuki Miyata
Aug 4, 2011·Journal of Thrombosis and Haemostasis : JTH·Y FujimuraT Miyata
May 26, 2012·British Journal of Haematology·Marie ScullyUNKNOWN British Committee for Standards in Haematology
Feb 21, 2013·Current Opinion in Pediatrics·Chantal LoiratAgnès Veyradier
May 30, 2013·Hämostaseologie·K KentoucheJ Windyga
May 27, 2014·Blood·Marie ScullyUNKNOWN collaborators of the UK TTP Registry
Aug 15, 2014·The New England Journal of Medicine·James N George, Carla M Nester
Nov 15, 2015·Journal of Thrombosis and Haemostasis : JTH·A S von KroghJ A Kremer Hovinga
Jul 9, 2013·Journal of Chemical Theory and Computation·Daniel R Roe, Thomas E Cheatham
Mar 5, 2016·Human Mutation·Johan T den DunnenPeter E M Taschner
Nov 22, 2016·Journal of Thrombosis and Haemostasis : JTH·M ScullyUNKNOWN International Working Group for Thrombotic Thrombocytopenic Purpura
Jan 25, 2017·Intensive Care Medicine·Bérangère S JolyAgnès Veyradier
Apr 7, 2017·Nature Reviews. Disease Primers·Johanna A Kremer HovingaKaren Vanhoorelbeke
Apr 19, 2017·Blood·Bérangère S JolyAgnès Veyradier
Dec 10, 2017·Journal of Thrombosis and Haemostasis : JTH·E RooseK Vanhoorelbeke

❮ Previous
Next ❯

Citations

Nov 11, 2020·Journal of Thrombosis and Haemostasis : JTH·Leydi Carolina Velásquez PereiraKaren Vanhoorelbeke
Mar 18, 2021·Journal of Thrombosis and Haemostasis : JTH·Charlotte DekimpeKaren Vanhoorelbeke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.